Hemagen Diagnostics, Inc.
HMGN · OTC
9/30/2012 | 6/30/2012 | 3/31/2012 | 12/31/2011 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $66 | $107 | $87 | $19 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $588 | $585 | $590 | $419 |
| Inventory | $1,363 | $1,367 | $1,366 | $1,568 |
| Other Curr. Assets | $78 | $85 | $118 | $133 |
| Total Curr. Assets | $2,095 | $2,144 | $2,161 | $2,139 |
| Property Plant & Equip (Net) | $282 | $312 | $355 | $391 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $66 | $65 | $78 | $56 |
| Total NC Assets | $348 | $377 | $433 | $447 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,443 | $2,521 | $2,594 | $2,587 |
| Liabilities | – | – | – | – |
| Payables | $369 | $0 | $0 | $0 |
| Short-Term Debt | $977 | $977 | $894 | $719 |
| Tax Payable | $65 | $0 | $0 | $0 |
| Deferred Revenue | $21 | $30 | $37 | $32 |
| Other Curr. Liab. | $518 | $899 | $857 | $827 |
| Total Curr. Liab. | $1,950 | $1,906 | $1,788 | $1,578 |
| LT Debt | $4,050 | $4,050 | $4,050 | $4,050 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $4,050 | $4,050 | $4,050 | $4,050 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $6,000 | $5,956 | $5,838 | $5,628 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $156 | $156 | $156 | $156 |
| Retained Earnings | -$26,678 | -$26,515 | -$26,383 | -$26,139 |
| AOCI | -$79 | -$95 | -$14 | -$31 |
| Other Equity | $23,044 | $23,020 | $22,996 | $22,973 |
| Total Equity | -$3,557 | -$3,434 | -$3,245 | -$3,042 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,443 | $2,521 | $2,594 | $2,587 |
| Net Debt | $4,960 | $4,919 | $4,857 | $4,750 |